Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ASA vs Chewable Aspirin PK/PD Study in Healthy Adults
NCT05625334Phase 1Completed
- Sponsor
- Vectura
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin in acute myocardial infarction (AMI) (2 arms), sponsored by Vectura. Primary endpoint: Serum thromboxane B2 AUEC of % Change from Baseline. Started Oct 2022; status: completed.
02
Drugs
aspirin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT05625334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05625334.